Membrane-initiated steroid signaling (MISS) is a recently discovered aspect of steroidal control over cell function that has proved highly challenging to study due to its rapidity and ultrasensitivity to the steroid trigger [Chow RWY, Handelsman DJ, Ng MKC (2010) Endocrinology 151:2411-2422]. Fundamental aspects underlying MISS, such as receptor binding, kinetics of ion-channel opening, and production of downstream effector molecules remain obscure because a pristine molecular technology that could trigger the release of signaling steroids was not available. We have recently described a prototype DNA nanocapsule which can be programmed to release small molecules upon photoirradiation [Veetil AT, et al. (2017) Nat Nanotechnol 12:1183-1189]. Here we show that this DNA-based molecular technology can now be programmed to chemically trigger MISS, significantly expanding its applicability to systems that are refractory to photoirradiation.
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estradiol | DNA nanotechnology | eNOS | cell signaling | live imaging S teroids execute their diverse biological functions through both membrane-initiated steroid signaling (MISS) and nuclear-initiated steroid signaling (NISS) (1) (2) (3) . MISS is a rapid process occurring within seconds to minutes after the steroid binds its cognate receptors on the plasma membrane (4) . In contrast, NISS is much slower, occurring over hours to days accompanied by transcriptional changes in the nucleus (5) . The role of NISS in reproduction, bone mineralization, lipid, and carbohydrate metabolism is well studied (6) . Despite the emerging importance of MISS in vascular systems, fundamental issues related to MISS, e.g., protein-protein interactions at the plasma membrane, second messenger dynamics, and downstream signaling molecules are unknown. MISS is particularly understudied in the central nervous system, where it plays a pivotal role in brain homeostasis and memory formation (7, 8) . The paucity of technologies available to manipulate signaling steroids has limited the pace of breakthroughs in understanding and manipulating MISS. Technologies that can offer a clean and controllable release of signaling steroids can open up new ways to study fundamental aspects of MISS such as activation timescales or second messenger dynamics and could potentially yield new insights into steroidal signaling.
DNA nanotechnology has been used to realize a plethora of well-defined 3D polyhedra by directed assembly (9) (10) (11) . DNA polyhedra have controllable dimensions and are addressable with single-nucleotide precision, with the Turberfield tetrahedron (12) and a DNA icosahedron being the most widely used for biological applications (13, 14) . Particularly, the DNA icosahedron has been used to encapsulate diverse cargo such as gold nanoparticles, fluorescent polymers (15, 16) , and quantum dots for bioimaging (13) . Recently, we have shown that small molecules can be released from DNA icosahedra in response to a light stimulus in transparent organisms (17) . Despite being a clean and traceless trigger, light can only be applied to systems that are transparent. Further, continuous irradiation leads to phototoxicity.
Here, we describe a technology that uses a chemical trigger for the release of signaling steroid molecules from DNA icosahedra. We have applied this technology to estradiol (E 2 ) as a signaling steroid, as estradiol is important for blood vessel integrity in endothelial cells, cell proliferation in cancer, and neurotransmission (7, 18) . We designed and synthesized chemically caged E 2 by covalently attaching the 3′ position of E 2 to dextran through a disulfide linkage. Encapsulating the E 2 -functionalized dextran within a DNA nanocapsule effectively prevents the interaction of E 2 moieties with the estrogen receptor ERα, present on the plasma membrane. Addition of small thiols such as L-cysteine releases defined amounts of E 2 by thiol exchange, thus inducing dose-dependent MISS in human umbilical vein endothelial (HUVEC) cells. E 2 thus released induces rapid calcium (Ca   2+   ) signaling and nitric oxide (NO) production in HUVECs, which can be fluorescently imaged in real time. We have used this technology to map the temporal dynamics of MISS-triggered Ca 2+ and NO signaling in HUVECs. Cargo encapsulation within the DNA icosahedron enables complete control over initiation of MISS. This study can be generalized to a variety of bioactive steroids, peptides, inhibitors, etc. to investigate MISS in diverse cellular contexts.
Thiol Addition Triggers Cargo Release from DNA Nanocapsule Previous studies from our laboratory have demonstrated the efficient encapsulation of 10-kDa FITC-dextran within a DNA icosahedron (see SI Appendix for assembly and encapsulation protocol) (14) . In this study, we have synthesized three different chemically caged small-molecule-dextran conjugates for encapsulation within DNA icosahedra. Dextran (10 kDa) was chemically linked to 4-methyl-umbelliferone (4-MU) or methoxyfluorescein through a disulfide linkage to display either fluoresceins (FLD 10 ) or coumarins (CD 10 ), respectively, on the dextran scaffold ( Fig. 1 B 
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Steroids execute their diverse biological functions through both membrane-initiated steroid signaling (MISS) and nuclearinitiated steroid signaling (NISS). NISS is much slower, occurring over hours to days accompanied by transcriptional changes in the nucleus and is well studied. In contrast MISS is more recently discovered--it is rapid, occurs within seconds upon binding the plasma membrane, and is much less studied. Despite its emerging importance, fundamental issues such as second messenger dynamics and downstream signaling molecules are still unknown because of the paucity of technologies available to manipulate signaling steroids. Here we describe a technology that offers a clean and controllable release of signaling steroids under chemical control that enables the study of MISS dynamics. and C). FLD 10 and CD 10 display on average two molecules of fluorophores per dextran. We also synthesized a nonfluorescent caged 17-β-estradiol-dextran conjugate, ED 10 using the same procedure (Fig. 1D ), also bearing two molecules of E 2 per dextran on average. Synthesis and characterization of all dextrans is detailed in SI Appendix, Figs. S3 and S4 and Schemes S1-S3. It is known from previous studies that the fluorescence of methoxyfluorescein and 4-MU are effectively quenched when they are derivatized as carbonates (17, 19) . Thus, in their chemically caged forms, both FLD 10 and CD 10 show extremely weak background fluorescence. Addition of thiols to FLD 10 , CD 10 , or ED 10 is expected to release free fluorophore or free E 2 from their chemically caged dextran precursors due to rapid thiol-disulphide exchange (Fig. 1C) .
We then tested the ability of FLD 10 to release fluorescein by adding dithiothreitol (DTT). Addition of DTT (2.5 mM) to FLD 10 (5 μM) in phosphate buffer (pH 7.2) triggered rapid methoxyfluorescein release given by the increase in fluorescence intensity at λ = 510 nm ( Fig. 2A) . The kinetics of methoxyfluorescein release from FLD 10 (Fig. 2B ) revealed that ∼50% of fluorophore was released within 2 min (t 1/2 ) of DTT addition. A similar response was also seen for CD 10 at 450 nm (SI Appendix, Fig. S7C ).
Size exclusion chromatography and dynamic light scattering (DLS) of FLD 10 and CD 10 (SI Appendix, Figs. S3 and S4) revealed sizes of 5.1 ± 1.1 and 4.6 ± 1.5 nm, indicating that they were within a suitable size regime for encapsulation in the DNA icosahedron. We encapsulated CD 10 within the DNA icosahedron to give I CD10 using published protocols (14) . Both agarose gel electrophoresis and DLS indicated the efficient formation and purity of I CD10 (SI Appendix, Fig. S6 ). We then showed that these DNA nanocapsules were stable toward exonucleases for up to 2 h at 37°C even when the constituent strands were unligated (SI Appendix, Fig. S10 ). To demonstrate the successful encapsulation of CD 10 to give I CD10 we also performed fluorescence anisotropy measurements on I CD10 . Free 4-MU (1 μM) in phosphate buffer at pH 7.2 showed an anisotropy r ∼ 0.020, while CD 10 showed an anisotropy of ∼0.033. This increase in mean anisotropy in CD 10 is consistent with the molecular mass increase of 10 kDa experienced by the coumarin fluorophores on CD 10 . Mean anisotropy of I CD10 showed a characteristic additional increase to ∼0.051 due to the restricted rotation of CD 10 nanocapsule (Fig. 2C) . This is in agreement with earlier studies conducted on other fluorescent dextrans encapsulated within the DNA icosahedron (14) . Addition of 2.5 mM of DTT to I CD10 decreased the r value from 0.051 to ∼0.02, corresponding to the anisotropy of free 4-MU proving the successful encapsulation of CD 10 (Fig. 2C ). Fluorescence and UV-visible spectroscopy of I CD10 revealed that on average two molecules of CD 10 were encapsulated per DNA nanocapsule (see SI Appendix for details), which is consistent with our previous studies (14) .
To further confirm CD 10 encapsulation, we subjected I CD10 to treatment with thiols of different sizes. Simulations and experiments have indicated that the DNA icosahedron has an effective in-circle diameter of ∼2.8 nm at its triangular face (13, 15) . This implies that small thiols with diameter ∼1 nm can rapidly permeate the DNA icosahedron and initiate thiol-disulfide exchange to release 4-MU. As expected, incubation of I CD10 for 1 h with H 2 S, DTT, or cysteine resulted in efficient release of 4-MU from I CD10 (Fig. 1D) . Thiols with larger diameter, such as polyethylene glycol thiol (PEG-SH, 2.3 nm) or dextran thiol (DEX-SH, 3.2 nm), showed ∼65% and ∼40% release in 1 h, respectively. Dextran thiol (40 kDa) with a diameter of 8.2 ± 1.1 nm showed negligible release of fluorophores (see also SI Appendix, Fig. S7F ). Due to their effective diameter, larger dextran thiols experience restricted access to the interior of the DNA nanocapsule and therefore cannot engage in disulfide exchange. Importantly, the low release efficiency observed with larger thiols is due to encapsulation and not because of slower reactivity of the bulky thiol employed (SI Appendix, Fig. S7F) 
For our subsequent studies on MISS, it was essential to estimate the amount of E 2 released as early as 10 s. Therefore, we conducted a detailed investigation of the kinetics of L-cysteineinduced 4-MU release from I CD10 (1 μM, phosphate buffer, pH 7.4) using fluorescence spectroscopy. We observed that 58 ± 3 nM of 4-MU was released within 10 s from I CD10 upon the addition of 1 mM cysteine, at pH 7.4 and 37°C (SI Appendix, Fig.  S11 A and B) . Thus, we may reliably estimate that I ED10 too would be expected to yield ∼60 nM of E 2 over 10 s under similar experimental conditions, using similar chemical trigger.
I ED10 Probes MISS-Induced Calcium Signaling in HUVECs
Next, we probed Ca 2+ signaling that is induced by estradiol (E 2 ) due to MISS in endothelial cells. E 2 functions as a vasodilator in the endothelium at picomolar to nanomolar concentrations (20) . It binds to the estrogen receptor, ERα present at the plasma membrane of endothelial cells and initiates intracellular Ca 2+ signaling (21) . Such nongenomic action of E 2 initiates within seconds along with the intracellular entry of free Ca 2+ ions. Previous studies have indicated the rapidity of Ca 2+ signaling triggered by E 2 in endothelial cells with little information about the actual timescales (20) . This is too fast to measure when E 2 is added directly into the system. HUVECs are highly sensitive to subnanomolar or even subpicomolar concentrations of E 2 , and concentration fluctuations are sufficient to trigger MISS in an uncontrolled, uncoordinated manner (SI Appendix, Fig. S9) .
We therefore probed Ca 2+ signaling induced by direct addition of E 2 (100 nM) to the extracellular medium of cultured HUVECs. To monitor this, HUVECs were loaded with the Ca 2+ sensing fluorophore Fluo-4 AM ester for 30 min before the experiment. Postincubation, excess Fluo-4 AM was washed off, the cells were mounted on a wide-field microscope, and 100 nM E 2 was added to the cell culture medium. Cells were imaged live in the Fluo-4 channel (λ em = 520 nm) to visualize increase in intracellular Ca 2+ (Fig. 3B and Movie S2). The initial burst of Ca 2+ could not be captured due to the rapidity of the signaling cascade and occurs within seconds as shown in Fig. 3E . Importantly, even upon progressively decreasing added E 2 from 100 nM to as low as 100 pM, the initial build-up of Ca 2+ signal evolution proved elusive (SI Appendix, Fig. S9 ). Next, we added 100 nM of caged estradiol, ED 10 , to Fluo-4-loaded HUVEC cells. The expectation is that only upon cysteine addition should E 2 be released from ED 10 to initiate MISSinduced Ca 2+ signaling. However, we observed Ca 2+ signaling in ED 10 -treated cells even without the addition of exogenous cysteine ( Fig. 3C and Movie S3). This is likely due to the capacity of E 2 to still engage its receptor even in its chemically caged form, ED 10, through its steroid moiety. Further addition of Cys to the cell culture media activated an additional ∼10% of cells, presumably due to the release of the payload of uncaged E 2 molecules (Fig.  3G ). Direct addition of cysteine (1 mM) alone did not elicit any observable Ca 2+ signal (Fig. 3G ). This also indicated that ED 10 did not prematurely release E 2 due to background hydrolysis, and that it was competent to release E 2 upon addition of cysteine.
Next (Fig. 3D) . Addition of 1 mM cysteine in HBSS to I ED10 -treated cells resulted in subsequent Ca 2+ spikes (Fig. 3D, red box) . Interestingly, we could now capture the complete evolution of the Ca 2+ signal, due to the steady ramp-up of E 2 released from I ED10 (Fig. 3F) . The use of a DNA nanocapsule with thiol-triggered release of E 2 provides a steady, homogeneous concentration ramp-up of E 2 in the extracellular medium, which results in the concordant activation of all cells at ∼10 s. I ED10 without the cysteine trigger showed only ∼10% of activated cells, which corresponds to the basal level of activation (Fig. 3G) . However, E 2 -and ED 10 -treated cells showed ∼47% and ∼37%, respectively, of preactivated cells in comparison (Fig. 3G) . Thus, using ED 10 or E 2 leads to premature activation of the ERα receptor. This illustrates that I ED10 offers a pristine way to initiate MISS using an endogenously available chemical trigger like cysteine because the DNA nanocapsule effectively prevents inadvertent receptor activation by sequestering ED 10 within its internal void.
I ED10 Reveals the Timescales of NO Production Induced by MISS
It is known that E 2 induces NO production in endothelial cells to orchestrate vasodilation (22, 23) . NO is produced in endothelial cells largely by the action of endothelial nitric oxide synthase (eNOS) (22) . In HUVECs eNOS is known to be activated when cytosolic Ca 2+ increases and is hypothesized to be contingent on its trafficking from the plasma membrane to intracellular compartments (23, 24) . However, neither the intracellular location at which eNOS becomes active nor its activation timescales are precisely known. It is also not known whether eNOS is active en route to the intracellular compartments. We therefore applied our technology to measure the time delay (t 1/2 ) between Ca 2+ elevation and NO production in HUVECs. In our subsequent studies we denote t 1/2 as the time interval between maximal Ca 2+ elevation and when NO production reaches half-maximum. Intracellular NO production was monitored with a specific fluorescent NO reporter DAF-2 acetate. We incubated HUVECs with DAF-2 acetate for 1 h before treating it with either E 2 , ED 10 , or I ED10 . E 2 -and ED 10 -treated cells showed significant NO production 20-min postincubation (Fig. 4 B and C) . Notably, ED 10 induced NO production even in the absence of cysteine (Fig. 4 C and G) in HUVECs, consistent with premature activation of cells seen earlier (Fig. 3 C and G) .
Next, we treated DAF-2-loaded cells with I ED10 , which affords chemical control over signaling using cysteine as a trigger. In the absence of any added cysteine, I ED10 -treated cells showed insignificant production of NO beyond basal levels (Fig. 4 E and G) . Addition of 1 mM cysteine induced efficient NO signaling in HUVEC cells as observed in Fig. 4 F and G at 20 min. DNA icosahedra not containing any ED 10 (I empty ) with or without cysteine could not induce NO production (Fig. 4 D and G) .
To quantify t 1/2 we monitored the rate of NO production in HUVECs by chemically triggered E 2 release from I ED10. DAF-2-loaded HUVEC cells were treated with I ED10 (1 μM), cysteine (1 mM) was added, and time-lapse fluorescence images were recorded. DAF-2 intensity in these images was plotted as a function of time (Fig. 4H) . Unlike the Ca 2+ signal, which showed an increase and then a decrease, DAF-2 intensity increased sigmoidally as DAF is not a reversible NO reporter. An overlay of the kinetics of cytosolic Ca 2+ levels and subsequent NO production reveals their relative temporal dynamics (Fig. 4H) . After E 2 release is triggered, an intracellular Ca 2+ spike occurs after ∼10 s. This is then followed by NO production that shows a t 1/2 of ∼4 min (Figs. 4H and 5) .
Immunofluorescence studies by Goetz et al. (20) revealed that upon stimulating bovine aortic endothelial cells (BAECs) with E 2 , it takes ∼15 min for eNOS to translocate from the plasma membrane to perinuclear regions. Interestingly, when ovine endothelial cells were stimulated with E 2 , extracellular NO measured by Chen et al. (25) peaked at t ∼ 5 min. In BAECs, however, ∼70% of eNOS dissociates from the plasma membrane within the first 5 min, which already suggests that the timescale of eNOS activation could be even shorter than the timescale of translocation. Our study reveals that intracellular NO is produced at t 1/2 = 4 min, which is consistent with eNOS being en route to its relocation to intracellular compartments. Thus, eNOS activation seems to correlate with the timescales of its dissociation from the plasma membrane.
Conclusions
In summary, we have developed a DNA-nanocapsule-based technology to investigate estradiol (E 2 )-induced MISS in HUVECs. This technology enabled us to monitor the full build-up and decay trace of intracellular Ca 2+ elevation post-E 2 release, which could not be obtained otherwise. Chemically caged E 2 was ineffective, as it prematurely activated ERα receptors. However, encapsulating chemically caged E 2 within a DNA icosahedron, I ED10 , prevented the engagement of the ERα receptor unless and until release with a cysteine trigger occurred. Thiol-disulphide exchange occurred within I ED10 to release E 2 , which then diffused out of the nanocapsule through its pores, engaged the ERα receptors, and initiated MISS. The rapid, homogeneous concentration ramp-up of E 2 achieved using this method enabled us to calculate the precise time delay between Ca 2+ elevation and NO production. The observed t 1/2 value from our experiments reveals that eNOS is active upon dissociation from the plasma membrane, during translocation, and well before it docks onto the intracellular compartments. Encapsulating ED 10 in a DNA icosahedron affords pristine chemical uncaging of steroidal molecules and tight control over MISS. We envisage that this technology can be generalized to a variety of MISS processes as well as to study signaling induced by neurotransmitters, peptides, lipids, and inhibitors. Thiol releases E 2 (orange star) from I ED10 . Released E 2 binds to ERα (navy blue) inducing rapid calcium influx via calcium channels in the plasma membrane (green). Elevated cytosolic calcium activates calmodulin (CaM), which in turn activates eNOS (magenta) at the plasma membrane, causing it to translocate to the intracellular compartment Activated NOS induces NO production in the cell.
